ROIV
Roivant Sciences Ltd

1,948
Mkt Cap
$14.15B
Volume
4.16M
52W High
$21.35
52W Low
$8.73
PE Ratio
-36.81
ROIV Fundamentals
Price
$20.26
Prev Close
$20.34
Open
$20.50
50D MA
$17.42
Beta
0.87
Avg. Volume
7.94M
EPS (Annual)
-$0.2371
P/B
3.22
Rev/Employee
$38,737.33
Loading...
Loading...
News
all
press releases
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells 287,283 Shares of Stock
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) major shareholder Vivek Ramaswamy sold 287,283 shares of the business's stock in a transaction dated Thursday, November 13th. The stock was sold...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells 539,650 Shares of Stock
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) major shareholder Vivek Ramaswamy sold 539,650 shares of Roivant Sciences stock in a transaction on Monday, November 17th. The shares were sold...
MarketBeat·2d ago
News Placeholder
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells 1,027,670 Shares of Stock
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) major shareholder Vivek Ramaswamy sold 1,027,670 shares of the company's stock in a transaction that occurred on Friday, November 14th. The stock...
MarketBeat·2d ago
News Placeholder
Roivant Sciences (NASDAQ:ROIV) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Roivant Sciences from a "strong sell" rating to a "hold" rating in a research report on Sunday...
MarketBeat·5d ago
News Placeholder
556,521 Shares in Roivant Sciences Ltd. $ROIV Purchased by Tiff Advisory Services LLC
Tiff Advisory Services LLC acquired a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
Candriam S.C.A. Buys 1,476,646 Shares of Roivant Sciences Ltd. $ROIV
Candriam S.C.A. increased its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 5,399.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The...
MarketBeat·5d ago
News Placeholder
Quinn Opportunity Partners LLC Makes New Investment in Roivant Sciences Ltd. $ROIV
Quinn Opportunity Partners LLC bought a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·6d ago
News Placeholder
Campbell & CO Investment Adviser LLC Has $1.18 Million Stock Position in Roivant Sciences Ltd. $ROIV
Campbell & CO Investment Adviser LLC raised its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 330.7% during the second quarter, according to the company in its most recent 13F...
MarketBeat·6d ago
News Placeholder
Roivant Sciences (NASDAQ:ROIV) Stock Price Expected to Rise, Citigroup Analyst Says
Citigroup lifted their price objective on Roivant Sciences from $25.00 to $26.00 and gave the stock a "buy" rating in a research report on Tuesday...
MarketBeat·8d ago
News Placeholder
Roivant Sciences (NASDAQ:ROIV) Releases Earnings Results, Misses Expectations By $0.13 EPS
Roivant Sciences (NASDAQ:ROIV - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.40) EPS for the quarter, missing analysts' consensus estimates of ($0.27) by...
MarketBeat·9d ago

Latest ROIV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.